Lundbeck
HLUN-B.CO
#2442
Rank
NZ$10.34 B
Marketcap
$10.84
Share price
0.62%
Change (1 day)
34.86%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$3.91 Billion

According to Lundbeck 's latest financial reports the company's total liabilities are NZ$3.91 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lundbeck - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$3.59 B-4.87%
2022-12-31NZ$3.78 B3.62%
2021-12-31NZ$3.64 B-16.4%
2020-12-31NZ$4.36 B-8.16%
2019-12-31NZ$4.75 B137.56%
2018-12-31NZ$2.00 B16.37%
2017-12-31NZ$1.71 B-20.01%
2016-12-31NZ$2.14 B-19.95%
2015-12-31NZ$2.68 B6.35%
2014-12-31NZ$2.52 B10.2%
2013-12-31NZ$2.29 B27.06%
2012-12-31NZ$1.80 B4.12%
2011-12-31NZ$1.73 B8.76%
2010-12-31NZ$1.59 B-27.88%
2009-12-31NZ$2.20 B36.04%
2008-12-31NZ$1.62 B23.55%
2007-12-31NZ$1.31 B7.24%
2006-12-31NZ$1.22 B27.82%
2005-12-31NZ$0.95 B2.34%
2004-12-31NZ$0.93 B